vs

Side-by-side financial comparison of CHEGG, INC (CHGG) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $72.7M, roughly 2.0× CHEGG, INC). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -49.4%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-15.5M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -35.4%).

Chegg, Inc., is an American educational technology company based in Santa Clara, California. It provides homework help, digital and physical textbook rentals, textbooks, online tutoring, and other student services, powered by artificial intelligence. The company has 6.6 million subscribers. Chegg has been widely criticized for facilitating cheating and academic dishonesty among students.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CHGG vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
2.0× larger
TOI
$142.0M
$72.7M
CHGG
Growing faster (revenue YoY)
TOI
TOI
+90.9% gap
TOI
41.6%
-49.4%
CHGG
More free cash flow
TOI
TOI
$17.7M more FCF
TOI
$2.2M
$-15.5M
CHGG
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-35.4%
CHGG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHGG
CHGG
TOI
TOI
Revenue
$72.7M
$142.0M
Net Profit
$-7.5M
Gross Margin
57.3%
Operating Margin
-47.2%
-4.9%
Net Margin
-5.3%
Revenue YoY
-49.4%
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-0.30
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHGG
CHGG
TOI
TOI
Q4 25
$72.7M
$142.0M
Q3 25
$77.7M
$136.6M
Q2 25
$105.1M
$119.8M
Q1 25
$121.4M
$104.4M
Q4 24
$143.5M
$100.3M
Q3 24
$136.6M
$99.9M
Q2 24
$163.1M
$98.6M
Q1 24
$174.3M
$94.7M
Net Profit
CHGG
CHGG
TOI
TOI
Q4 25
$-7.5M
Q3 25
$-17.5M
$-16.5M
Q2 25
$-35.7M
$-17.0M
Q1 25
$-17.5M
$-19.6M
Q4 24
$-13.2M
Q3 24
$-212.6M
$-16.1M
Q2 24
$-616.9M
$-15.5M
Q1 24
$-1.4M
$-19.9M
Gross Margin
CHGG
CHGG
TOI
TOI
Q4 25
57.3%
Q3 25
59.2%
Q2 25
66.3%
Q1 25
55.5%
Q4 24
68.2%
Q3 24
68.2%
Q2 24
72.2%
Q1 24
73.3%
Operating Margin
CHGG
CHGG
TOI
TOI
Q4 25
-47.2%
-4.9%
Q3 25
-22.0%
-5.9%
Q2 25
-34.7%
-9.4%
Q1 25
-23.9%
-9.5%
Q4 24
-19.0%
-11.9%
Q3 24
-162.7%
-13.9%
Q2 24
-297.3%
-16.6%
Q1 24
-1.4%
-19.0%
Net Margin
CHGG
CHGG
TOI
TOI
Q4 25
-5.3%
Q3 25
-22.5%
-12.1%
Q2 25
-33.9%
-14.2%
Q1 25
-14.4%
-18.8%
Q4 24
-13.1%
Q3 24
-155.7%
-16.1%
Q2 24
-378.1%
-15.7%
Q1 24
-0.8%
-21.0%
EPS (diluted)
CHGG
CHGG
TOI
TOI
Q4 25
$-0.30
$-0.04
Q3 25
$-0.16
$-0.14
Q2 25
$-0.33
$-0.15
Q1 25
$-0.17
$-0.21
Q4 24
$-0.03
$-0.14
Q3 24
$-2.05
$-0.18
Q2 24
$-6.01
$-0.17
Q1 24
$-0.01
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHGG
CHGG
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$72.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$119.6M
$-15.7M
Total Assets
$278.0M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHGG
CHGG
TOI
TOI
Q4 25
$72.8M
Q3 25
$96.4M
Q2 25
$85.6M
Q1 25
$88.3M
Q4 24
$315.7M
Q3 24
$361.1M
Q2 24
$345.5M
$9.9M
Q1 24
$390.8M
$29.8M
Stockholders' Equity
CHGG
CHGG
TOI
TOI
Q4 25
$119.6M
$-15.7M
Q3 25
$146.1M
$-12.3M
Q2 25
$157.9M
$-9.0M
Q1 25
$185.7M
$5.1M
Q4 24
$193.0M
$3.6M
Q3 24
$185.0M
$15.5M
Q2 24
$365.5M
$29.2M
Q1 24
$963.5M
$41.3M
Total Assets
CHGG
CHGG
TOI
TOI
Q4 25
$278.0M
$164.7M
Q3 25
$378.3M
$163.6M
Q2 25
$404.5M
$159.8M
Q1 25
$438.8M
$164.0M
Q4 24
$869.0M
$172.7M
Q3 24
$1.0B
$179.2M
Q2 24
$1.1B
$179.6M
Q1 24
$1.7B
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHGG
CHGG
TOI
TOI
Operating Cash FlowLast quarter
$-9.0M
$3.2M
Free Cash FlowOCF − Capex
$-15.5M
$2.2M
FCF MarginFCF / Revenue
-21.3%
1.5%
Capex IntensityCapex / Revenue
8.9%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.6M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHGG
CHGG
TOI
TOI
Q4 25
$-9.0M
$3.2M
Q3 25
$4.8M
$-12.6M
Q2 25
$-4.8M
$-10.2M
Q1 25
$24.5M
$-5.0M
Q4 24
$18.1M
$4.2M
Q3 24
$39.5M
$819.0K
Q2 24
$14.2M
$-15.7M
Q1 24
$53.3M
$-15.9M
Free Cash Flow
CHGG
CHGG
TOI
TOI
Q4 25
$-15.5M
$2.2M
Q3 25
$-943.0K
$-13.2M
Q2 25
$-12.1M
$-11.4M
Q1 25
$15.9M
$-5.3M
Q4 24
$4.8M
$2.4M
Q3 24
$23.7M
$417.0K
Q2 24
$-3.6M
$-17.5M
Q1 24
$25.3M
$-16.5M
FCF Margin
CHGG
CHGG
TOI
TOI
Q4 25
-21.3%
1.5%
Q3 25
-1.2%
-9.7%
Q2 25
-11.5%
-9.5%
Q1 25
13.1%
-5.1%
Q4 24
3.4%
2.4%
Q3 24
17.3%
0.4%
Q2 24
-2.2%
-17.7%
Q1 24
14.5%
-17.4%
Capex Intensity
CHGG
CHGG
TOI
TOI
Q4 25
8.9%
0.7%
Q3 25
7.4%
0.4%
Q2 25
6.9%
1.0%
Q1 25
7.1%
0.3%
Q4 24
9.3%
1.8%
Q3 24
11.6%
0.4%
Q2 24
10.9%
1.9%
Q1 24
16.1%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHGG
CHGG

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons